1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Sunniva Inc.

Sunniva Inc.

SNNVF
Sunniva Inc.US flagOther OTC
0.00
USD
- -
- -
3,921.00Market Cap
Sunniva Inc.
SNNVF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
TTM
FRC
- -
0.52
0.59
0.78
Revenue per Share
-0.22
-0.57
-0.91
-1.29
Basic EPS, GAAP
-0.36
-0.58
-2.06
-1.51
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
0.45
0.85
1.8
0.66
Book Value per Share
0.02
-0.31
1.2
0.73
Tangible Book Value per Share
31
31
32
39
Basic Weighted Avg Shares
- -
16
19
30
Sales/Revenue/Turnover
-10,221.05
-87.92
-149.46
-104.06
Operating Margin (%)
- -
3
3
5
Depreciation Expense
-7
-18
-29
-50
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
-18,123.68
-108.97
-154.6
-164.86
Profit Margin (%)
-1
-1
-1
8
Working Capital
- -
21
20
42
LT Debt
14
34
85
54
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
-88.16
-69.93
-139.69
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'19
Jun'19
Sep'19
ST Debt
8
9
16
LT Borrowings
22
22
24
LT Finance Leases
15
16
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
39
39
39
Market Capitalization
152
100
50

Working Capital

FRC

•

in mil. unless spec.
Mar'19
Jun'19
Sep'19
Total Current Assets
25
37
42
Cash, Cash Equivalents & STI
2
2
- -
Accounts Receivable, Net
10
6
4
Inventories
8
5
3
Total Current Liabilities
21
29
34
Payables & Accruals
13
12
9
ST Debt
8
9
16
Deferred Revenue
- -
1
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
147.86%
Free Cash Flow
- -
- -
269.96%
Net Income, GAAP
- -
- -
65.87%
Sales/Revenue/Turnover
- -
- -
16.91%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
2
3
5
6
16
2018
5
4
1
5
19
2019
14
5
5
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
-0.03
-0.35
-0.2
- -
-0.57
2018
-0.23
-0.16
-0.21
- -
-0.91
2019
-0.09
-0.39
-0.52
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
Similar Companies
Shineco, Inc. (TYHT)
Kotra Industries Berhad (0002.KL)
THC Biomed Intl Ltd. (THCBF)
JW Pharmaceutical Corporation (001067.KS)
Kaken Pharmaceutical Co., Ltd. (4521.T)
New Leaf Ventures Inc (NLVVF)
Business
Sunniva Inc. (SNNVF), a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of therapeutic cannabis solutions in Canada and the United States; the company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments and offers products under the Sun Fire, Kyndness, and Herbella brands. Founded in 2014 and headquartered in Vancouver, Canada, Sunniva provides medical cannabis products and services, including sun-grown premium cannabis, ultra-purified extracts, vaporizers, and patient education through owned clinics such as Natural Health Services Ltd., which serves over 95,000 active patients; it targets medical cannabis patients and physicians in key markets like California and Canada. Recent major changes include the delisting of its common shares from the Canadian Securities Exchange on October 10, 2024, amid ongoing suspension since 2020; earlier divestitures such as the 2019 sale of Natural Health Services to Cura-Can Health Corp. for CA $9 million in cash and shares, the 2020 reversal of a distribution facility acquisition, and the ceasing of operations at Full-Scale Distributors LLC in 2020 to preserve cash amid disputes over its Cathedral City greenhouse lease.

Company News

APIChatGPT

  • globenewswire.com

    Sunniva Announces Update on Audit and Arbitration Matters